The inhibitory activity of a new peptidyl
collagenase inhibitor,
FN-439 or tetrapeptidyl
hydroxamic acid (H2N-C6H4-CO-Gly-L-Pro-D-Leu-D-Ala-NHOH), was determined against vertebrate
collagenases derived from human fibroblast, human polymorphonuclear leukocyte (PMN) and tadpole skin. In addition, the effect of
FN-439 in inhibiting corneal ulceration was also investigated with
alkali-burned rabbit corneas.
FN-439 can block the active site of
collagenase, and
hydroxamic acid can chelate Zn2+ which is essential for
collagenase activity. Furthermore, this compound contains D-
amino acids to resist nonspecific host-derived degradative
enzymes. In our experiments, corneal ulceration occurred in 5 of the 9 control eyes, but in none of the 9 eyes treated with
FN-439 (P < 0.01). The only cellular elements observed at the ulcerated area were PMNs and monocytes.
FN-439 appeared to act against PMN
collagenase. In addition, we compared the change in the concentration of
FN-439 (D-
peptide) and the L-form of
FN-439 (L-
peptide) in aqueous humor aspirated from the rabbit eyes burned with
alkali. After incubation for 3 hours, the concentration of the D-
peptide was decreased by 3%, while that of the L-
peptide was decreased by 60%.
FN-439 may be useful for treating noninfectious corneal
ulcers because of its potent activity (IC50 = 1 microM) and chemical and
biological stabilities.